Estee Lauder Companies (NYSE:EL) Stock Price Expected to Rise, UBS ...
📈 UBS Group raised Estee Lauder's price target to $86.00, suggesting a 4.47% upside from the prior close while maintaining a neutral rating.
📉 Wall Street Zen downgraded the stock from buy to hold, and Telsey Advisory Group reduced their price objective from $105.00 to $90.00.
💰 Citigroup increased their target price to $110.00 and upgraded the rating to buy, citing strong performance potential.
📊 The company reported Q1 EPS of $0.91, beating analyst estimates of $0.66 by a margin of $0.25.
💵 Revenue for the quarter totaled $3.71 billion, surpassing the consensus forecast of $3.69 billion.
📈 Year-over-year revenue growth was recorded at 4.6%, indicating steady top-line expansion.
🎯 Management set full-year 2026 EPS guidance between $2.330 and $2.430, with analysts averaging a prediction of $2.41.
🏦 Institutional ownership stands at 55.15%, reflecting continued confidence from major market participants.
📈 Walker Asset Management LLC initiated a new stake worth $209,000 in the second quarter.
📈 Tema ETFs LLC increased its position by 9.3%, now holding 5,100 shares valued at $403,000.
📈 Handelsbanken Fonder AB boosted its stake by 18.1%, acquiring an additional 24,322 shares.
📈 Czech National Bank increased its holdings by 4.5%, adding 3,059 shares to its portfolio.
📈 PensionDanmark grew its position by 9.7%, purchasing an additional 3,200 shares in the quarter.
🏢 The company operates as a global leader in prestige beauty with a diverse portfolio including Estée Lauder, Clinique, MAC, and La Mer.
📉 The firm reported a negative net margin of 1.67% despite maintaining a positive return on equity of 20.66%.
- Estee Lauder beat quarterly EPS estimates significantly with $0.91 actual versus $0.66 consensus, demonstrating strong operational execution.
- Revenue of $3.71 billion exceeded analyst expectations of $3.69 billion, confirming robust demand for the company's products.
- The company achieved a 4.6% year-over-year revenue increase, highlighting successful growth in its core business segments.
- Citigroup upgraded the stock to a buy rating and raised the price target to $110.00, signaling strong institutional confidence.
- Multiple large institutional investors increased their stakes in Q2, including Walker Asset Management, Tema ETFs, and Handelsbanken.
- The company maintains a healthy positive return on equity of 20.66%, indicating efficient use of shareholder capital.
- Wall Street Zen downgraded the stock from buy to hold, reflecting some caution among analysts regarding current valuation or outlook.
- Telsey Advisory Group lowered their price objective to $90.00 and assigned a market perform rating, suggesting limited upside potential.
- Weiss Ratings maintained a sell rating, albeit slightly improved from d+ to d, indicating lingering concerns about the stock's trajectory.